Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy
Authors
Keywords
-
Journal
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Volume 48, Issue 2, Pages 160-166
Publisher
Oxford University Press (OUP)
Online
2017-11-22
DOI
10.1093/jjco/hyx179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (S010) Stereotactic Body Radiotherapy (SBRT) for Operable vs. Medically Inoperable Stage I Non-Small Cell Lung Cancer: Long-Term Five-Year Outcomes and an Assessment by Fractionation Regimen, Tumor Size, and Tumor Location
- (2017) Caitlin A. Schonewolf et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- The prognostic impact of tumor volume on stage I non-small cell lung cancer
- (2017) Xiao-Dong Su et al. LUNG CANCER
- Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models
- (2017) Feng Liu et al. RADIOTHERAPY AND ONCOLOGY
- Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse
- (2016) Gokoulakrichenane Loganadane et al. CANCER TREATMENT REVIEWS
- The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
- (2016) John M. Stahl et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
- (2016) Michael B. Bernstein et al. Nature Reviews Clinical Oncology
- Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters
- (2016) Zhiguo Zhou et al. RADIOTHERAPY AND ONCOLOGY
- Recurrence Risk-Scoring Model for Stage I Adenocarcinoma of the Lung
- (2015) Hee Chul Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions
- (2015) A. Filatenkov et al. CLINICAL CANCER RESEARCH
- Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC
- (2015) Zain A. Husain et al. Clinical Lung Cancer
- Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model
- (2015) Alexander V. Louie et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
- (2015) Yasushi Nagata et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer
- (2015) Wenhua Liang et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC
- (2015) Liseth L. van den Berg et al. Journal of Thoracic Oncology
- Relationship Between Tumor Size and Survival in Non–Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry
- (2015) Jianjun Zhang et al. Journal of Thoracic Oncology
- Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer
- (2015) Nathan A. Cannon et al. Journal of Thoracic Oncology
- FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer
- (2015) Zachary A. Kohutek et al. LUNG CANCER
- CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
- (2015) Thibaud P. Coroller et al. RADIOTHERAPY AND ONCOLOGY
- Comparison of Effects Between Central and Peripheral Stage I Lung Cancer Using Image-Guided Stereotactic Body Radiotherapy via Helical Tomotherapy
- (2015) Jian He et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer
- (2015) Seong Yong Park et al. CANCER IMAGING
- Pretreatment [18F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status
- (2014) Vimoj J. Nair et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis
- (2014) Feifei Na et al. Journal of Thoracic Oncology
- Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
- (2014) Zachary D Horne et al. Radiation Oncology
- A National Study of Nodal Upstaging After Thoracoscopic Versus Open Lobectomy for Clinical Stage I Lung Cancer
- (2013) Peter B. Licht et al. ANNALS OF THORACIC SURGERY
- Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer
- (2013) Xiao-Yi Duan et al. BMC CANCER
- Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after Stereotactic Body Radiotherapy
- (2013) Atsuya Takeda et al. Journal of Thoracic Oncology
- Prognostic Value of Primary Tumor FDG Uptake for Occult Mediastinal Lymph Node Involvement in Clinically N2/N3 Node-negative Non–Small Cell Lung Cancer
- (2012) Andrew D. Trister et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery
- (2012) Jeffrey M. Albert et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
- (2012) Hongyoon Choi et al. LUNG CANCER
- Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
- (2012) Yuko Shirata et al. Radiation Oncology
- Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?
- (2012) Katy Clarke et al. RADIOTHERAPY AND ONCOLOGY
- Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer
- (2011) Sameer K. Nath et al. RADIOTHERAPY AND ONCOLOGY
- Association Between 18F-Fluoro-2-Deoxy-d-Glucose Uptake Values and Tumor Vitality: Prognostic Value of Positron Emission Tomography in Early-Stage Non-small Cell Lung Cancer
- (2010) Christophe Dooms et al. Journal of Thoracic Oncology
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer: The Pattern of Failure Is Distant
- (2009) Jeffrey D. Bradley et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Fluorodeoxyglucose positron emission tomography and tumor marker expression in non–small cell lung cancer
- (2009) Matthew D. Taylor et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Individualized Prediction of Colon Cancer Recurrence Using a Nomogram
- (2008) Martin R. Weiser et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-individualized stereotactic body radiotherapy for T1–3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapy
- (2008) Yongshun Chen et al. RADIOTHERAPY AND ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started